8:00-9:00 A.M.

WORKING BREAKFAST

9:00 A.M.

PUBLIC WORKSHOP BEGINS

9:00-9:10 A.M.

Welcome and Introductory Remarks

9:10-9:55 A.M.

EXTENDING THE SPECTRUM OF PRECOMPETITIVE ONCOLOGY BIOMEDICAL RESEARCH: A SUMMARY

Moderator: Martha Turner, American Nurses Association

9:10-9:35 A.M.

Lessons Learned

Stephen Friend, President and Chief Executive Officer (CEO), Sage Bionetworks

9:35-9:55 A.M.

Discussion

9:55-11:30 A.M.

REQUISITES FOR SUCCESSFUL PRECOMPETITIVE COLLABORATION

Moderator: Sharon Terry, Genetic Alliance

9:55-10:15 A.M.

The Architecture of Collaboration

William J. Spencer, Chairman Emeritus, SEMATECH

10:15-10:35 A.M.

Requisites from the Pharmaceutical Industry

Aidan Power, Vice President and Global Head of Molecular Medicine, Pfizer Inc.

10:35-10:50 A.M.

BREAK

10:50-11:10 A.M.

Requisites from Diagnostic Companies

Marcia Eisenberg, Senior Vice President, LabCorp

11:10-11:30 A.M.

Requisites from Academia

Neal Cohen, Vice Dean, School of Medicine, Professor of Anesthesia and Perioperative Care and Medicine, Director of International Medical Services, University of California, San Francisco

12:30-2:05 P.M.

FRAMEWORK OF COLLABORATIONS WITH THE PHARMACEUTICAL INDUSTRY

Moderator: Aidan Power, Pfizer Inc.

12:30-12:50 P.M.

Public–Private Partnerships with NIH or Government

Thomas Insel, Director of the National Institute of Mental Health, National Institutes of Health

12:50-1:10 P.M.

Advancing Technological Achievements Through Collaboration

Christopher Beecher, Research Professor, Michigan Center for Translational Pathology, University of Michigan

1:10-1:30 P.M.

Open Access Partnerships

Aled Edwards, Director and CEO, Structural Genomics Consortium; Professor, Department of Medical Biophysics, University of Toronto

1:30-1:50 P.M.

Access to Large-Scale Data Networks

Stephen Friend, President and CEO, Sage Bionetworks

1:50-2:05 P.M.

BREAK

2:05-4:05 P.M.

BIOSPECIMENS

Moderator: Geoffrey Ginsburg, Duke University

2:05-2:25 P.M.

Sustaining Access to Biospecimens

Martin Yuille, Reader in Biobanking, Co-director, Centre for Integrated Genomic Medical Research, University of Manchester

2:25-2:45 P.M.

Developing Common Biorepository Infrastructures

2:45-3:05 P.M.

Linking Health Outcomes Data to Biorepository Samples

Cynthia Helphingstine, President and CEO, Fairbanks Institute for Healthy Communities

3:05-3:25 P.M.

Creating a National Virtual Biospecimen Bank

Lorraine Q. Frazier, Nancy B. Willerson Distinguished Professorship, Assistant Dean & Department Chair, Nursing Systems, Professor, Department of Nursing Systems, University of Texas Health Science Center at Houston

3:25-3:45 P.M.

Opportunities and Challenges of Clinical and Genetic Data Access in the Pharmaceutical Industry

Sally John, Head of Human Genetics, Molecular Medicine, PharmaTherapeutics Research, Pfizer Inc.

3:45-4:05 P.M.

Ethical Challenges for Biospecimen and Data Sharing

Ellen Wright Clayton, Rosalind E. Franklin Professor of Genetics and Health Policy; Director, Center for Biomedical Ethics and Society, Vanderbilt University

4:05-5:05 P.M.

PANEL DISCUSSION

4:05 - 5:05 P.M.

Developing a cultural, legal, and behavioral framework of collaboration that enables resource sharing in order to accelerate genomics-based drug and diagnostic product development

Moderator: Stephen Eck, Eli Lilly and Company

Panelists:

Kelly Edwards, Associate Professor, Department of Bioethics and Humanities, University of Washington School of Medicine

Lorraine Q. Frazier, Nancy B. Willerson Distinguished Professorship, Assistant Dean & Department Chair, Nursing Systems, Professor, Department of Nursing Systems, University of Texas Health Science Center at Houston

Geoffrey Ginsburg, Director, Center for Genomic Medicine, Institute for Genomic Sciences & Policy, Duke University

Garry Neil, Corporate Vice President, COSAT, Johnson & Johnson

William J. Spencer, Chairman Emeritus, SEMATECH

Sharon Terry, President and CEO, Genetic Alliance

5:05-5:30 P.M.

SUMMARY AND CONCLUSIONS